Olimel N12e (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin)

Olimel N12e provides a comprehensive amino‑acid profile tailored for clinical nutrition support. It is used in the following contexts:

• Post‑operative recovery: Helps maintain nitrogen balance and supports tissue repair.
• Severe malnutrition: Supplies essential amino acids to restore protein stores.
• Critical illness or trauma: Contributes to metabolic stability and immune function.
• Long‑term parenteral nutrition: Provides a balanced amino‑acid solution for patients unable to use the gastrointestinal tract.

• The amino‑acid blend in Olimel N12e is absorbed directly into the bloodstream after intravenous administration, bypassing gastrointestinal digestion. Individual amino acids act as substrates for protein synthesis, serve as precursors for neurotransmitters and hormones, and participate in gluconeogenesis and nitrogen transport, thereby supporting cellular growth and repair processes.

Adverse reactions to Olimel N12e are generally related to its intravenous administration and the amino‑acid composition.

Common Side Effects

• Mild infusion‑site erythema
• Transient nausea
• Slight increase in serum urea
• Temporary elevation of liver enzymes
• Mild headache
• Low‑grade fever

Serious or Rare Side Effects

• Anaphylactic or severe hypersensitivity reaction
• Acute metabolic acidosis
• Hyperammonemia
• Severe electrolyte imbalance
• Thromboembolic events
• Renal dysfunction

When using Olimel N12e, clinicians should observe the following precautions:

• Assess renal function: Adjust dosing in patients with impaired clearance.
• Monitor liver enzymes: Watch for signs of hepatic stress.
• Check electrolyte status: Correct imbalances before infusion.
• Observe for hypersensitivity: Discontinue if severe reaction occurs.
• Use aseptic technique: Prevent contamination during preparation.
• Store at ambient temperature: keep in original container, protect from moisture and direct light.

Olimel N12e may interact with other agents administered intravenously. Awareness of the following interactions helps maintain safety:

Major Interactions (Avoid)

• Concurrent high‑dose potassium chloride: risk of hyperkalemia.
• Large-volume dextrose solutions: may cause osmotic shifts.

Moderate Interactions (Monitor Closely)

• Loop diuretics: may exacerbate electrolyte loss.
• Anticoagulants anticoagulants: alter clotting parameters.
• Other parenteral nutrition modules: risk of cumulative amino‑acid excess.
• Acid‑base modifying agents: affect metabolic balance.
• Certain antibiotics antibiotics: may precipitate in mixed solutions.